Medical Imaging Institute of Tianjin, Tianjin, China.
Cytotherapy. 2010 Nov;12(7):859-69. doi: 10.3109/14653241003587652.
Negative-contrast magnetic resonance imaging (MRI) methods utilizing magnetic susceptibility contrast agents have become one of the most widely used approaches in cellular imaging research. However, visualizing and tracking super-paramagnetic iron oxide nanoparticle (SPIO)-labeled cells on the basis of negative-contrast can limit specificity and sensitivity. Therefore, there has been a strong motivation to explore MRI methods for cellular imaging with either positive or dual contrast (both positive and negative) for identifying labeled cells; these methods offer the potential to improve significantly the sensitivity and specificity of MRI-based cell-tracking approaches. In this review, current state-of-the-art positive- and dual-contrast MRI techniques and contrast agents are described specifically for applications involving in vivo cellular tracking and imaging.
利用顺磁对比剂的负对比磁共振成像(MRI)方法已成为细胞成像研究中最广泛应用的方法之一。然而,基于负对比来可视化和跟踪超顺磁氧化铁纳米颗粒(SPIO)标记的细胞可能会限制其特异性和灵敏度。因此,人们强烈希望探索用于细胞成像的 MRI 方法,这些方法具有正对比或双对比(正负对比)的特性,用于识别标记的细胞;这些方法有可能显著提高基于 MRI 的细胞跟踪方法的灵敏度和特异性。在这篇综述中,特别描述了用于体内细胞跟踪和成像的应用的最新正对比和双对比 MRI 技术和对比剂。
Cytotherapy. 2010-11
Contrast Media Mol Imaging. 2015
Magn Reson Med. 2014-5
ACS Appl Mater Interfaces. 2013-10-1
Mol Imaging. 2009
Metab Brain Dis. 2015-2
Adv Drug Deliv Rev. 2014-2